4.7 Review

COVID-19: Mechanisms of Vaccination and Immunity

Journal

VACCINES
Volume 8, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/vaccines8030404

Keywords

SARS-CoV-2; COVID-19; nucleic acid tests; serology; vaccination; immunity

Funding

  1. Swiss National Science Foundation (SNF) [31003A 149925, 310030-179459]
  2. University of Lausanne, Switzerland
  3. International Immunology Centre, Anhui Agricultural University, Hefei, China
  4. University of Bern, Switzerland

Ask authors/readers for more resources

Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines that induce large quantities of high affinity virus-neutralizing antibodies may optimally prevent infection and avoid unfavorable effects. Vaccination trials require precise clinical management, complemented with detailed evaluation of safety and immune responses. Here, we review the pros and cons of available vaccine platforms and options to accelerate vaccine development towards the safe immunization of the world's population against SARS-CoV-2. Favorable vaccines, used in well-designed vaccination strategies, may be critical for limiting harm and promoting trust and a long-term return to normal public life and economy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available